Chi Charles Gu

Chi Charles Gu

Auto-generated profile, based on publicly available information

Chi Charles Gu

Division of Biology & Biomedical Sciences, Washington University School of Medicine, St. Louis, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Cell Metabolism
Verified
Journal Article
Closed access
JYJun Yoshino
Jun Yoshino
Caterina ConteCaterina Conte
Caterina Conte
LFLuigi Fontana
Luigi Fontana
BMBettina Mittendorfer
Bettina Mittendorfer
SIShin-Ichiro Imai
Shin-Ichiro Imai
SKSamuel Klein
Samuel Klein

1 July 2012 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TCThe Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium
The Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium
XLXiangfeng Lu
Xiangfeng Lu
LWLaiyuan Wang
Laiyuan Wang
SCShufeng Chen
Shufeng Chen
LHLin He
Lin He
DGDongfeng Gu
Dongfeng Gu

23 January 2005 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
XZXiaofeng Zhu
Xiaofeng Zhu
ALAmy Luke
Amy Luke
RCRichard S Cooper
Richard S Cooper
TQTom Quertermous
Tom Quertermous
CHCraig Hanis
Craig Hanis
AWAlan Weder
Alan Weder

12 September 2017 in BMC Genomics
Verified
Journal Article
Open access
PDF file
JZJia Zhou
Jia Zhou
RSRenee L. Sears
Renee L. Sears
XXXiaoyun Xing
Xiaoyun Xing
BZBo A Zhang
Bo A Zhang
DLDaofeng Li
Daofeng Li
TWTing Wang
Ting Wang
Uncovering mechanisms of epigenome evolution is an essential step towards understanding the evolution of different cellular phenotypes. While studies have confirmed DNA methylation as a conserved epigenetic mechanism in mammalian development, little is known about the conservation of tissue-specific genome-wide DNA methylation patterns. Using a comparative epigenomics approach, we identified and compared the tissue-specific DNA methylation patterns of rat against those of mouse and human across three shared tissue types. We confirmed that tissue-specific differentially methylated regions are strongly associated with tissue-specific regulatory elements. Comparisons between species revealed that at a minimum 11-37% of tissue-specific DNA methylation patterns are conserved, a phenomenon that we define as epigenetic conservation. Conserved DNA methylation is accompanied by conservation of other epigenetic marks including histone modifications. Although a significant amount of locus-specific methylation is epigenetically conserved, the majority of tissue-specific DNA methylation is not conserved across the species and tissue types that we investigated. Examination of the genetic underpinning of epigenetic conservation suggests that primary sequence conservation is a driving force behind epigenetic conservation. In contrast, evolutionary dynamics of tissue-specific DNA methylation are best explained by the maintenance or turnover of binding sites for important transcription factors. Our study extends the limited literature of comparative epigenomics and suggests a new paradigm for epigenetic conservation without genetic conservation through analysis of transcription factor binding sites.

8 April 2022 in Science Advances
Verified
Journal Article
Closed access
TNTetsushi Nakao
Tetsushi Nakao
ABAlexander G Bick
Alexander G Bick
MTMargaret A Taub
Margaret A Taub
SZSeyedeh M Zekavat
Seyedeh M Zekavat
MUM Uddin
M Uddin
PNPradeep Natarajan
Pradeep Natarajan
Human genetic studies support an inverse causal relationship between leukocyte telomere length (LTL) and coronary artery disease (CAD), but directionally mixed effects for LTL and diverse malignancies. Clonal hematopoiesis of indeterminate potential (CHIP), characterized by expansion of hematopoietic cells bearing leukemogenic mutations, predisposes both hematologic malignancy and CAD. TERT (which encodes telomerase reverse transcriptase) is the most significantly associated germline locus for CHIP in genome-wide association studies. Here, we investigated the relationship between CHIP, LTL, and CAD in the Trans-Omics for Precision Medicine (TOPMed) program ( n = 63,302) and UK Biobank ( n = 47,080). Bidirectional Mendelian randomization studies were consistent with longer genetically imputed LTL increasing propensity to develop CHIP, but CHIP then, in turn, hastens to shorten measured LTL (mLTL). We also demonstrated evidence of modest mediation between CHIP and CAD by mLTL. Our data promote an understanding of potential causal relationships across CHIP and LTL toward prevention of CAD.

3 December 2002 in The FASEB Journal
Verified
Journal Article
Closed access
PDF file
TMThomas J. Mariani
Thomas J. Mariani
VBVikram Budhraja
Vikram Budhraja
BMBrigham H. Mecham
Brigham H. Mecham
CGC. Charles Gu
C. Charles Gu
MWMark A. Watson
Mark A. Watson
YSYoel Sadovsky
Yoel Sadovsky